Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation
- PMID: 34508661
- DOI: 10.1016/j.immuni.2021.08.012
Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation
Abstract
Langerhans cells (LCs) play a pivotal role in skin homeostasis, and the heterogeneity of LCs has long been considered. In this study, we have identified two steady-state (LC1 and LC2) and two activated LC subsets in the epidermis of human skin and in LCs derived from CD34+ hemopoietic stem cells (HSC-LCs) by utilizing single-cell RNA sequencing and mass cytometry. Analysis of HSC-LCs at multiple time-points during differentiation revealed that EGR1 and Notch signaling were among the top pathways regulating the bifurcation of LC1 and LC2. LC1 were characterized as classical LCs, mainly related to innate immunity and antigen processing. LC2 were similar to monocytes or myeloid dendritic cells, involving in immune responses and leukocyte activation. LC1 remained stable under inflammatory microenvironment, whereas LC2 were prone to being activated and demonstrated elevated expression of immuno-suppressive molecules. We revealed distinct human LC subsets that require different developmental regulation and orchestrate reciprocal functions.
Keywords: Langerhans cells; differentiation; function; heterogeneity; human; mass cytometry; phenotype; single-cell RNA sequencing.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests The authors declare no competing interests.
Comment in
-
Many Langerhans make light work of skin immunity.Immunity. 2021 Oct 12;54(10):2188-2190. doi: 10.1016/j.immuni.2021.09.006. Immunity. 2021. PMID: 34644554
-
Defining the landscape of human epidermal mononuclear phagocytes.Immunity. 2023 Mar 14;56(3):459-460. doi: 10.1016/j.immuni.2023.02.001. Immunity. 2023. PMID: 36921567 No abstract available.
-
Response to identifying the epidermal dendritic cell landscape.Immunity. 2023 Mar 14;56(3):461-462. doi: 10.1016/j.immuni.2023.02.006. Immunity. 2023. PMID: 36921568 No abstract available.